Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Holiday notice

    BioCentury Extra will not publish on Thursday, Nov. 24, or Friday, Nov. 25, in observance of the Thanksgiving holiday in the U.S. BioCentury Extra will resume publishing on Monday, Nov. 28.

    Published on 11/23/2016
  • FINANCIAL NEWS: Arch raises $408.4M toward ninth fund

    Arch Venture Partners has raised $408.4 million towards its Arch Venture Fund IX LP, according to an SEC filing. The fund's target is $550 million, up from a planned $400 million in March.According to a separate filing,…

    Published on 11/21/2016
  • FINANCIAL NEWS: Aclaris raises $91M in follow-on

    Aclaris Therapeutics Inc. (NASDAQ:ACRS) raised $91 million through the sale of 4 million shares at $22.75 in a follow-on underwritten by Jefferies, Leerink, Guggenheim Securities, William Blair and JPM Securities. The …

    Published on 11/17/2016
  • FINANCIAL NEWS: Biocartis raises EUR 32.7M in private placement

    Molecular diagnostics company Biocartis Group N.V. (Euronext:BCART) raised EUR 32.7 million ($35.1 million) through the sale of 4.1 million shares at EUR 8.05 in a private placement underwritten by Degroof Petercam, KBC…

    Published on 11/17/2016
  • FINANCIAL NEWS: Invitae raises $44M in follow-on

    Diagnostic company Invitae Corp. (NYSE:NVTA) raised $44 million through the sale of 7.3 million shares at $6 in a follow-on underwritten by JPMorgan and Cowen. The price is a 30% discount to the company's $8.53 closing …

    Published on 11/17/2016
  • FINANCIAL NEWS: Flexion falls after $64.8M follow-on

    Flexion Therapeutics Inc. (NASDAQ:FLXN) raised $64.8 million through the sale of 3.6 million shares at $18 in a follow-on underwritten by Wells Fargo, RBC Capital Markets and BMO Capital Markets.The price is an 11% …

    Published on 11/16/2016
  • FINANCIAL NEWS: Glycomine raises $12M in series A round

    Rare disease company Glycomine Inc. (San Francisco, Calif.) raised $12 million in a series A round led by Sanderling Ventures and Chiesi Ventures.The company's preclinical lead program is substrate replacement therapy …

    Published on 11/16/2016
  • FINANCIAL NEWS: Stem cell newco Magenta raises $48.5M

    Magenta Therapeutics (Cambridge, Mass.) raised $48.5 million in a series A round led by Third Rock Ventures and Atlas Venture. GV, Access Industries and Partners Innovation Fund also participated. By developing a three-…

    Published on 11/16/2016
  • FINANCIAL NEWS: BeyondSpring aiming for $100M IPO

    BeyondSpring Pharmaceuticals Inc. (New York, N.Y.) proposed to raise up to $100 million in an IPO on NASDAQ underwritten by Citigroup, Guggenheim Securities, FBR, China Renaissance and Trout Capital.The company plans to…

    Published on 11/15/2016
  • FINANCIAL NEWS: MorphoSys raises EUR 115.4M in private placement

    MorphoSys AG (Xetra:MOR; Pink:MPSYY) raised EUR 115.4 million ($123.8 million) through the sale of 2.6 million shares at EUR 44 in a private placement underwritten by Deutsche Bank and JPMorgan.MorphoSys gained EUR 0.44…

    Published on 11/15/2016
  • FINANCIAL NEWS: Tesaro raises $236.3M in follow-on

    Tesaro Inc. (NASDAQ:TSRO) raised $236.3 million through the sale of 1.8 million shares at $135 in a follow-on underwritten by Citigroup, Leerink, Credit Suisse, Wells Fargo, Baird, FBR, Guggenheim, Raymond James, …

    Published on 11/15/2016
  • FINANCIAL NEWS: Alexion slips as Street digests whistleblower allegations

    Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) slid $13.26 (10%) to $113.62 on Friday, reflecting continued investor concerns after the company on Wednesday said it was delaying its 3Q16 10-Q filing while it investigates a …

    Published on 11/11/2016
  • FINANCIAL NEWS: Betta rises after RMB720M Shenzhen listing

    Betta Pharmaceuticals Co. Ltd. (SZSE:300558) raised about RMB720 million ($106.3 million) through the sale of 41 million shares at RMB17.57 in an IPO underwritten by CICC. The price valued Betta at RMB7 billion ($1 …

    Published on 11/8/2016
  • FINANCIAL NEWS: CureVac raises $29.5M

    CureVac AG (Tuebingen, Germany) raised $29.5 million in a private round led by two new investors -- Baden-Wuerttembergische Versorgungsanstalt fuer Aerzte, Zahnaerzte und Tieraerzte; and Landeskreditbank Baden-…

    Published on 11/8/2016
  • FINANCIAL NEWS: Early Nuplazid sales boost Acadia shares

    Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) gained $3.85 (17%) to $26.84 after it reported 3Q16 earnings that included stronger than expected early sales data for Nuplazid pimavanserin. Acadia launched the drug in late …

    Published on 11/8/2016
  • FINANCIAL NEWS: Qiming closes RMB1.5B fund

    Qiming Venture Partners closed its fourth renminbi fund at RMB1.5 billion ($221.4 million). The firm invests in healthcare companies as well as IT and cleantech, primarily in growth stage companies.The firm now has $2.7…

    Published on 11/8/2016
  • FINANCIAL NEWS: Syncona pooling resources with U.K. cancer investors

    The Syncona investment arm of the Wellcome Trust and cancer-focused investment firm BACIT Ltd. (LSE:BACT) proposed a deal in which they would combine to form a publicly traded life sciences investment company with about…

    Published on 11/7/2016
  • FINANCIAL NEWS: Versant targeting $350M for sixth fund

    Versant Ventures is targeting $350 million for Versant Venture Capital VI, according to an SEC filing. The firm declined to discuss the new fund.In 2014, Versant closed its fifth life sciences fund at $305 million. The …

    Published on 11/7/2016
  • FINANCIAL NEWS: Nestle investing $145M in Aimmune

    The Nestle Health Science subsidiary of Nestle S.A. (SIX:NESN) will invest $145 million in food allergy company Aimmune Therapeutics Inc. (NASDAQ:AIMT) through the purchase of 7.6 million shares at $19.20. The price is…

    Published on 11/4/2016
  • FINANCIAL NEWS: Biotech stocks near 2016 lows

    Biotech indices neared their lowest levels of the year after several disappointing data readouts on Thursday. The BioCentury 100 Index slipped 164.85 (3.5%) to close at 4,520.64, approaching its 2016 bottom on Feb. 11, …

    Published on 11/3/2016
  • FINANCIAL NEWS: Genmab lifts guidance as Darzalex shows new promise

    Genmab A/S (CSE:GEN) raised full-year 2016 guidance as it reported 3Q16 earnings that beat estimates, with a boost from royalty and milestone revenue related to multiple myeloma drug Darzalex daratumumab. New data from …

    Published on 11/3/2016
  • FINANCIAL NEWS: NBE raises CHF20M in series B

    NBE-Therapeutics AG (Basel, Switzerland) raised CHF20 million ($20.2 million) in a series B financing led by PPF Group. Boehringer Ingelheim Venture Fund also participated, as did all of the company's existing private …

    Published on 11/3/2016
  • FINANCIAL NEWS: Turnstone raises $41.4 million series B round

    Turnstone Biologics Inc. (Toronto, Ontario) raised $41.4 million in a series B round led by new investor OrbiMed. First-time investor F-Prime Capital Partners and existing investors FACIT and Versant Ventures also …

    Published on 11/2/2016
  • FINANCIAL NEWS: Veracyte raises $30M in follow-on

    Molecular diagnostics company Veracyte Inc. (NASDAQ:VCYT) raised $30 million through the sale of 5 million shares at $6 in a follow-on underwritten by Leerink and BTIG. The price is a 16% discount to Veracyte's $7.13 …

    Published on 11/2/2016
  • FINANCIAL NEWS: Acesion raises EUR 9.1M in series A

    Cardiology company Acesion Pharma ApS (Copenhagen, Denmark) raised EUR 9.1 million ($10 million) in a series A round from existing investors Novo Seeds and the Wellcome Trust. CEO Frans Wuite told BioCentury the company…

    Published on 11/1/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993